Clonal expansion of B-cells in human systemic lupus erythematosus : evidence from studies before and after therapeutic B-cell depletion
Anti-B-cell therapy may be beneficial for patients with SLE and active proliferative glomerulonephritis. Using genomic DNA, we examined how rituximab-induced transient B-cell depletion affected the composition of immunoglobulin heavy-chain (Ig-VH/DH/JH) repertoire at the time-point of 33-35% B-cell...
Ausführliche Beschreibung
Bibliographische Detailangaben
Veröffentlicht in: | Clinical immunology (Orlando, Fla.). - 1999. - 132(2009), 1 vom: 15. Juli, Seite 19-31
|
1. Verfasser: |
Sfikakis, Petros P
(VerfasserIn) |
Weitere Verfasser: |
Karali, Vassiliki,
Lilakos, Konstantinos,
Georgiou, George,
Panayiotidis, Panayiotis |
Format: | Online-Aufsatz
|
Sprache: | English |
Veröffentlicht: |
2009
|
Zugriff auf das übergeordnete Werk: | Clinical immunology (Orlando, Fla.)
|
Schlagworte: | Clinical Trial
Journal Article
Research Support, Non-U.S. Gov't
Antibodies, Monoclonal
Antibodies, Monoclonal, Murine-Derived
Complementarity Determining Regions
Immunoglobulin Heavy Chains
Immunologic Factors
Rituximab
4F4X42SYQ6 |